🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Byron Gajewski

Byron Gajewski

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial”.

Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial

EClinicalMedicine(2021)10.1016/j.eclinm.2021.100905

N/A

2.3DataRank · unranked

92 citations

Byron Gajewski, Christina J. Valentine, Elizabeth H. Kerling, Carl P. Weiner, Michael Cackovic +8 more

The Effect of Prenatal Docosahexaenoic Acid Supplementation on Offspring Fat Mass and Distribution at 24 Months Old

Current Developments in Nutrition(2024)10.1016/j.cdnut.2024.103771

N/A

0.216DataRank · unranked

3 citations

Alexandra R. Brown, Byron Gajewski, Debra K. Sullivan, Susan E. Carlson, Holly R. Hull

“How cliff shaped my philosophy on faculty development and mentorship: A remembrance”

Chemometrics and Intelligent Laboratory Systems(2020)10.1016/j.chemolab.2020.104094

N/A

0DataRank · unranked

0 citations

Byron Gajewski

Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials

BMC Medical Research Methodology(2020)10.1186/s12874-020-01071-2

N/A

0DataRank · unranked

0 citations

Byron Gajewski, Xiaqing Huang

Estimating power for clinical trials with Patient Reported Outcomes - using Item Response Theory

Journal of Clinical Epidemiology(2021)10.1016/j.jclinepi.2021.10.002

N/A

0DataRank · unranked

8 citations

Jeffrey Thompson, Dinesh Pal Mudaranthakam, Lynn Chollet Hinton, David Streeter, Michele Park +3 more

Bayesian EMAX model with a mixture of normal distributions for dose–response in clinical trials

Contemporary Clinical Trials(2021)10.1016/j.cct.2021.106571

N/A

0DataRank · unranked

3 citations

Susan E. Carlson, Jo Wick, Byron Gajewski, Fengming Tang

Effects of Prenatal DHA Dose on Infant Visual Attention

Developmental Psychobiology(2025)10.1002/dev.70072

N/A

0DataRank · unranked

4 citations

D. Jill Shaddy, Nicole Mathis, Danielle Christifano, Alexandra R. Brown, Byron Gajewski +3 more

Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials

BMC Medical Research Methodology(2020)10.1186/s12874-020-01097-6

N/A

0DataRank · unranked

5 citations

Jo Wick, Renee Martin, Caitlyn Meinzer, Dooti Roy, Byron Gajewski +1 more

Mediators of the Effect of Opt-In Versus Opt-Out Treatment on Smoking Cessation in a Randomized Clinical Trial

Nicotine & Tobacco Research(2025)10.1093/ntr/ntaf265

N/A

0DataRank · unranked

1 citations

Byron Gajewski, Delwyn Catley, Babalola Faseru, Piali Dey Bristi, Kimber Richter +1 more

Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials

Research Square(2020)10.21203/rs.2.20244/v2

N/A

0DataRank · unranked

1 citations

Byron Gajewski, Xiaqing Huang